“Farber Disease Market” report has been added to DelveInsight
The Farber Disease market report provides an edge while developing business strategies, by understanding trends shaping and driving the global Farber Disease Market
Download free sample copy here- https://www.delveinsight.com/sample-request/farbers-disease-market
Farber Disease: Overview
ASAH1-related disorders are an extremely rare group of disorders caused by an alteration (mutation) in the ASAH1 gene. Alterations in this gene result in a deficiency of the enzyme acid ceramidase. Enzymes are specialized proteins that act to bring about biochemical reactions in the body. The acid ceramidase enzyme is required to help break down certain fatty substances – called ceramides – in the body.
Farber Disease: Geography Covered
• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan
Farber Disease Key Players
- Avrobio
- Freeline
Farber Disease Drugs
- AVR-RD-01
- FTL190
Farber Disease Causes
This can cause a variety of signs and symptoms based on where the fatty substance builds up and how much of it builds up. The most common form of ASAH1-related disorder is called Farber disease, which can present in several different ways.
Farber’s disease, also known as Farber’s lipogranulomatosis, describes a group of inherited metabolic disorders called lipid storage diseases, in which excess amounts of lipids (oils, fatty acids, and related compounds) build up to harmful levels in the joints, tissues, and central nervous system. The liver, heart, and kidneys may also be affected. Disease onset typically begins in early infancy but may occur later in life.
Farber Disease Symptoms
Symptoms of the classic form may have moderately impaired mental ability and difficulty with swallowing. Other symptoms may include chronic shortening of muscles or tendons around joints. Arthritis, swollen lymph nodes and joints, hoarseness, nodules under the skin (and sometimes in the lungs and other parts of the body), and vomiting. Some people may need a breathing tube. In severe cases, the liver and spleen are enlarged. Farber’s disease is caused by a deficiency of the enzyme ceramidase.
Farber Disease Market Outlook
The disease occurs when both parents carry and pass on the defective gene that regulates the protein sphingomyelin. Children born to these parents have a 25 percent chance of inheriting the disorder and a 50 percent chance of carrying the faulty gene. The disorder affects both males and females.
Farber Disease Treatment Market
Sometimes, Farber disease is broken down into subtypes based on age of onset and specific symptoms and severity. However, these disorders are best thought of as a spectrum of disease ranging from mild forms that can go undiagnosed into adulthood to forms that cause severe, even life-threatening complications in infancy. These are: Farber Disease Type 1, Farber Disease Type 2, Farber Disease Type 3, Farber Disease Type 4, Farber Disease Type 5, Farber Disease Type 6, and Farber Disease Type 7.
Farber Disease Market: Report Scope
• The report covers the descriptive overview of Farber’s disease, explaining its causes, signs and symptoms, pathophysiology, and currently available therapies
• Comprehensive insight has been provided into the Farber’s disease epidemiology and treatment in the 7MM
• Additionally, an all-inclusive account of both the current and emerging therapies for Farber’s disease is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
• A detailed review of Farber’s disease market; historical and forecasted, is included in the report, covering drug outreach in the 7MM
• The report provides an edge while developing business strategies by understanding trends shaping and driving the global Farber’s disease market
Following is the TOC of Farber Disease market report
1. Key Insights
2. Farber Disease: Market Overview at a Glance
3. Organizations
4. Executive Summary
5. Disease Overview: Farber Disease
6. Epidemiology and Patient Population
7. 7MM Epidemiology of Farber Disease
8. Treatment and Management
9. Unmet Needs
10. Emerging Therapies
11. Farber Disease: 7 Major Market Analysis
12. Market Outlook: 7MM
13. Market Drivers
14. Market Barriers
15. Market Access and Reimbursement
16. SWOT Analysis
17. Case Studies
18. KOL views
19. Bibliography
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Why should you buy this report?
• The report will help in developing business strategies by understanding trends shaping and driving the Farber’s disease market
• To understand the future market competition in the Farber’s disease market and Insightful review of the key market drivers and barriers.
• Organize sales and marketing efforts by identifying the best opportunities for Farber’s disease in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
• Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors.
• Organize sales and marketing efforts by identifying the best opportunities for Farber’s disease market.
• To understand the future market competition in the Farber’s disease market.
Contact Us
Shruti Thakur
info@delveinsight.com
USA: – +1(919)321-6187
India:- +91-11-45689769, +91-9650213330
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Vinita Rakheja
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: www.delveinsight.com/